2018-2023 Global Epigenetic Market Report (Status and Outlook)
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Epigenetic market for 2018-2023.
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
United States will continue to dominate the Epigenetic market for due to high availability of funding for research.
The growing government initiatives and increasing number of Biotechnology and Biopharmaceutical companies in APAC is also driving the market of epigenetic in APAC.
Over the next five years, LPI(LP Information) projects that Epigenetic will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Epigenetic market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
DNA modifying Enzymes
RNA modifying Enzymes
Segmentation by application:
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Contract Research Organizations
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Epigenetic market size by key regions/countries, product type and application.
To understand the structure of Epigenetic market by identifying its various subsegments.
Focuses on the key global Epigenetic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Epigenetic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Epigenetic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Epigenetic Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Epigenetic Market Size 2018-2023
2.1.2 Epigenetic Market Size CAGR by Region
2.2 Epigenetic Segment by Type
2.2.1 DNA modifying Enzymes
2.2.2 RNA modifying Enzymes
2.2.3 Protein Modifying Enzymes
2.3 Epigenetic Market Size by Type
2.3.1 Global Epigenetic Market Size Market Share by Type (2018-2023)
2.3.2 Global Epigenetic Market Size Growth Rate by Type (2018-2023)
2.4 Epigenetic Segment by Application
2.4.1 Academic Research Institutes
2.4.2 Biotechnology Companies
2.4.3 Biopharmaceutical Companies
2.4.4 Diagnostic Companies
2.4.5 Contract Research Organizations
2.5 Epigenetic Market Size by Application
2.5.1 Global Epigenetic Market Size Market Share by Application (2018-2023)
2.5.2 Global Epigenetic Market Size Growth Rate by Application (2018-2023)
3 Epigenetic Key Players
3.1 Date of Key Players Enter into Epigenetic
3.2 Key Players Epigenetic Product Offered
3.3 Key Players Epigenetic Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End Industry
3.5 Key Players Epigenetic Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Epigenetic by Regions
4.1 Epigenetic Market Size by Regions
4.2 Americas Epigenetic Market Size Growth
4.3 APAC Epigenetic Market Size Growth
4.4 Europe Epigenetic Market Size Growth
5 Americas
5.1 Americas Epigenetic Market Size by Countries
5.2 Americas Epigenetic Market Size by Type
5.3 Americas Epigenetic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Epigenetic Market Size by Countries
6.2 APAC Epigenetic Market Size by Type
6.3 APAC Epigenetic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Epigenetic by Countries
7.2 Europe Epigenetic Market Size by Type
7.3 Europe Epigenetic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in Epigenetic
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.4.1 Company D Company Details
9.4.2 Company Description
9.4.3 Companies Invested by Company D
9.4.4 Company D Key Development and Market Layout
…
10 Key Players Analysis
10.1 Illumina
10.1.1 Company Details
10.1.2 Epigenetic Product Offered
10.1.3 Illumina Epigenetic Market Size
10.1.4 Main Business Overview
10.1.5 Illumina News
10.2 Qiagen
10.2.1 Company Details
10.2.2 Epigenetic Product Offered
10.2.3 Qiagen Epigenetic Market Size
10.2.4 Main Business Overview
10.2.5 Qiagen News
10.3 Abcam
10.3.1 Company Details
10.3.2 Epigenetic Product Offered
10.3.3 Abcam Epigenetic Market Size
10.3.4 Main Business Overview
10.3.5 Abcam News
10.4 Merck & Co
10.4.1 Company Details
10.4.2 Epigenetic Product Offered
10.4.3 Merck & Co Epigenetic Market Size
10.4.4 Main Business Overview
10.4.5 Merck & Co News
10.5 Sigma-Aldrich
10.5.1 Company Details
10.5.2 Epigenetic Product Offered
10.5.3 Sigma-Aldrich Epigenetic Market Size
10.5.4 Main Business Overview
10.5.5 Sigma-Aldrich News
10.6 New England Biolabs
10.6.1 Company Details
10.6.2 Epigenetic Product Offered
10.6.3 New England Biolabs Epigenetic Market Size
10.6.4 Main Business Overview
10.6.5 New England Biolabs News
10.7 Thermo Fisher Scientific
10.7.1 Company Details
10.7.2 Epigenetic Product Offered
10.7.3 Thermo Fisher Scientific Epigenetic Market Size
10.7.4 Main Business Overview
10.7.5 Thermo Fisher Scientific News
10.8 Diagenode
10.8.1 Company Details
10.8.2 Epigenetic Product Offered
10.8.3 Diagenode Epigenetic Market Size
10.8.4 Main Business Overview
10.8.5 Diagenode News
10.9 Active Motif
10.9.1 Company Details
10.9.2 Epigenetic Product Offered
10.9.3 Active Motif Epigenetic Market Size
10.9.4 Main Business Overview
10.9.5 Active Motif News
10.10 Roche Diagnostics
10.10.1 Company Details
10.10.2 Epigenetic Product Offered
10.10.3 Roche Diagnostics Epigenetic Market Size
10.10.4 Main Business Overview
10.10.5 Roche Diagnostics News
10.11 Eisai
10.12 Novartis
11 Research Findings and Conclusion
